Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Buy Low, Sell High, Get Paid To Wait (5 Easy Examples)
06:12am, Monday, 09'th Sep 2024
Buy Low, Sell High, Get Paid To Wait: Our simple investment philosophy focuses on purchasing assets at a discount to their intrinsic value. Key factors for maximizing profit include industry growth, m
2 Biotech Bets to Buy in September
12:32pm, Sunday, 08'th Sep 2024
Biotech investing is a thrill-a-minute ride. Biotech stocks can take investors soaring to new heights and fabulous wealth opportunities or send them into the pits of despair.
Buy 3 September Dogs Of The Dow; Watch 6
01:00am, Saturday, 07'th Sep 2024
"The Dow® [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
10:01am, Friday, 06'th Sep 2024
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Amgen Inc. (AMGN) Wells Fargo 2024 Healthcare Conference (Transcript)
01:47pm, Thursday, 05'th Sep 2024
Amgen Inc. (NASDAQ:AMGN ) Wells Fargo 2024 Healthcare Conference Call September 5, 2024 9:30 AM ET Company Participants Justin Claeys - Vice President of Investor Relations Jay Bradner - Executive Vic
Amgen (AMGN) Up 5.8% Since Last Earnings Report: Can It Continue?
12:37pm, Thursday, 05'th Sep 2024
Amgen (AMGN) reported earnings 30 days ago. What's next for the stock?
Amgen Stock Rises Almost 20% in 6 Months: Buy, Sell or Hold?
12:16pm, Thursday, 05'th Sep 2024
AMGN's reasonable valuation, an interesting pipeline and continued top-line growth are good enough reasons to stay invested for now.
Why the Market Dipped But Amgen (AMGN) Gained Today
06:56pm, Wednesday, 04'th Sep 2024
In the closing of the recent trading day, Amgen (AMGN) stood at $330.64, denoting a +0.04% change from the preceding trading day.
Amgen Inc. (AMGN) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)
12:25pm, Wednesday, 04'th Sep 2024
Amgen Inc. (NASDAQ:AMGN ) Morgan Stanley 22nd Annual Global Healthcare Conference September 4, 2024 9:15 AM ET Company Participants Bob Bradway - Chairman and Chief Executive Officer Conference Call P
Amgen to test its obesity drug in patients at risk of obesity-related diseases
10:08am, Wednesday, 04'th Sep 2024
Amgen will test its obesity drug candidate in patients at risk of obesity-related conditions such as heart, liver and kidney diseases in its late-stage trial, the company's CEO Robert Bradway said at
Novo, Amgen, Other Pharma Stocks Have Clinical Trials That Could Send Them Soaring
12:00am, Tuesday, 03'rd Sep 2024
From obesity to cancer, investors will do well to watch these 6 clinical trials.
AMGEN TO PRESENT AT THE 2024 WELLS FARGO HEALTHCARE CONFERENCE
04:00pm, Friday, 30'th Aug 2024
THOUSAND OAKS, Calif. , Aug. 30, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2024 Wells Fargo Healthcare Conference at 9:30 a.m.
AMGEN TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE
04:00pm, Thursday, 29'th Aug 2024
THOUSAND OAKS, Calif. , Aug. 29, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Morgan Stanley 22nd Annual Global Healthcare Conference at 9:15 a.m.
The 9 Pharma Stocks To Watch — Including Viking, Roche And Amgen — Amid The Fast-Growing Obesity Drug Race
01:19pm, Thursday, 29'th Aug 2024
The weight-loss drugs market could be worth up to $144 billion within six years. And a bevy of pharma stocks could get a lift.
Amgen's GLP-1 Upside Is Not Priced In
01:01am, Thursday, 29'th Aug 2024
Amgen's stock is fairly valued at 16.6x next year's earnings, supported by robust existing revenue growth and a diversified portfolio. The company's new products, such as Blincyto, Tezspire, and Tepez
